Shares of NRC Health NRC have declined 8.3% since the company reported its earnings for the quarter ended June 30, 2026. This compares to the S&P 500 index’s 1.5% growth over the same time frame. Over the past month, the stock has declined 13.3% compared with the S&P 500’s 1% decrease.NRC Health re…
Q2 saw 11% TRCV and 4% revenue growth year-over-year, with strong performance in Experience and The Governance Institute segments. Adjusted EBITDA margin held at 27%, and a landmark customer win began revenue recognition. Market uncertainty persists due to industry consolidation.Based on NRC Health…
Q2 saw 11% TRCV and 4% revenue growth year-over-year, with strong performance in Experience and Governance segments. Margins held steady as investments continued, and a major customer win began revenue contribution. Market uncertainty persists due to competitor consolidation.Based on NRC Health [NR…
NRC (NRC Health) is set to announce its Q2'26 results on July 28, after the market closes. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q2'26, revenue estimate is 34.90 million USD with EPS (earnings per share) anticipated at (0.15) USD. Learn more details at NRC Financ…
